(Q38335822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jan Däbritz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

6

Dirk Foell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Sharon D'Mello

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mi-Ok Kim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Erin Bonkowski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jon Meddings

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Bruce C Trapnell

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Lee A Denson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pediatric Gastroenterology and Nutrition

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

542-548

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease

29 January 2020

cites work

1 reference

12 December 2020

Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk

1 reference

12 December 2020

GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1.

1 reference

12 December 2020

Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease

1 reference

12 December 2020

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

1 reference

12 December 2020

Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease

1 reference

12 December 2020

Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in wisconsin: a statewide population-based study

1 reference

12 December 2020

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract

1 reference

12 December 2020

Sargramostim for active Crohn's disease

1 reference

12 December 2020

Hyperresponsiveness of the Mucosal Barrier in Crohnʼs Disease Is Not Tumor Necrosis Factor-Dependent

1 reference

12 December 2020

Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?

1 reference

12 December 2020

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

1 reference

12 December 2020

Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities

1 reference

12 December 2020

Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation

1 reference

12 December 2020

The role of lipopolysaccharide-binding protein in modulating the innate immune response

1 reference

12 December 2020

Defective acute inflammation in Crohn's disease: a clinical investigation

1 reference

12 December 2020

Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease

1 reference

12 December 2020

Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.

1 reference

12 December 2020

Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes

1 reference

12 December 2020

Immunogenetic phenotypes in inflammatory bowel disease

1 reference

12 December 2020

The epidemiology of inflammatory bowel disease in Canada: a population-based study

1 reference

12 December 2020

Impaired innate immunity in Crohn's disease

1 reference

12 December 2020

Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor.

1 reference

12 December 2020

Crohn's disease: innate immunodeficiency?

1 reference

12 December 2020

GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis

1 reference

12 December 2020

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

1 reference

12 December 2020

The measurement and clinical significance of intestinal permeability.

1 reference

12 December 2020

What role does intestinal permeability have in IBD pathogenesis?

1 reference

12 December 2020

Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage

1 reference

12 December 2020

Intestinal permeability in the pathogenesis of NSAID-induced enteropathy

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.

1 reference

12 December 2020

Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs

1 reference

12 December 2020

Sargramostim in patients with Crohn's disease: results of a phase 1-2 study

1 reference

12 December 2020

Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.

1 reference

12 December 2020

Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis.

1 reference

12 December 2020

Small bowel permeability in patients with nasal polyposis

1 reference

12 December 2020

Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor

1 reference

12 December 2020

Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease

1 reference

12 December 2020

Intestinal permeability in patients with Crohn's disease

1 reference

12 December 2020

Is small intestinal permeability really increased in relatives of patients with Crohn's disease?

1 reference

12 December 2020

Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease

1 reference

12 December 2020

10.1097/MPG.0B013E3181FE2D93

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502824%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

21502824

1 reference